Wegovy® (semaglutide) (0.25 mg)

£1,349.00

Wegovy® (semaglutide) 0.25 mg weekly injection is a prescription drug approved by the FDA to help adults who are overweight or obese and have health problems linked to their weight. This product comes in 4 pre-filled pens, which is enough for 28 days. It helps control blood sugar, lower hunger, and make you feel full when used with a healthy diet and regular exercise.

Category: Alluvi Tags: 0.25 mg semaglutide, appetite control injection, FDA approved weight loss, GLP-1 receptor agonist, obesity treatment, prescription weight management, semaglutide injection, weekly weight loss injection, Wegovy, weight loss medication

Description
Reviews (0)

Wegovy® (semaglutide) weekly injection – 0.25 mg, 4 pens, 28‑day supply

Wegovy 0.25 mg is an FDA‑approved prescription injectable medication designed for chronic weight management in adults with obesity or overweight with at least one weight-related condition, such as type 2 diabetes, high blood pressure, or high cholesterol. Each pen contains 0.25 mg of semaglutide, a GLP‑1 receptor agonist that works by reducing appetite, increasing feelings of fullness, and helping regulate blood sugar levels. Administered once weekly via subcutaneous injection, Wegovy® supports clinically proven weight loss when combined with a reduced-calorie diet and increased physical activity.

Dosage form: pre-filled injection pens | Quantity: 4 pens per 28-day supply | Price: $1,349 (cash price, U.S.)

Wegovy 0.25 mg must be used under the guidance of a licensed healthcare provider. Proper dose escalation is recommended to minimize gastrointestinal side effects and optimize results.